Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Targeting resident astrocytes attenuates neuropathic pain after spinal cord injury

Targeting resident astrocytes attenuates neuropathic pain after spinal cord injury

eLife, 2024 · DOI: https://doi.org/10.7554/eLife.95672 · Published: November 15, 2024

Spinal Cord InjuryNeurologyPain Management

Simple Explanation

This study investigates the role of different types of astrocytes in neuropathic pain following spinal cord injury (SCI). By selectively eliminating resident astrocytes in mice, the researchers aimed to understand if this could reduce SCI-induced neuropathic pain. The researchers used transgenic mice and viral vectors to target and eliminate resident astrocytes in the lumbar enlargement of the spinal cord. Pain-related behaviors were then measured using various methods to assess the impact of astrocyte elimination. The study found that eliminating resident astrocytes attenuated neuropathic pain and activated microglia, with the type I interferons (IFNs) signal significantly activated in microglia. This suggests that targeting type I IFNs signals could be an effective strategy for neuropathic pain treatment after SCI.

Study Duration
Not specified
Participants
132 Gt(ROSA)26Sorem1(CAG-­LSL-­tdTomato-­2A-­DTR)Smoc mice
Evidence Level
Level II: Experimental study in animal model

Key Findings

  • 1
    Resident astrocytes, not ependymal cells, are the primary source of astrocytes that induce neuropathic pain after SCI.
  • 2
    Selective elimination of resident astrocytes in the lumbar enlargement significantly reduced neuropathic pain in mice after SCI.
  • 3
    Eliminating resident astrocytes led to the activation of microglia and the type I interferon (IFN) signaling pathway in the lumbar enlargement.

Research Summary

This study demonstrates that resident astrocytes, rather than ependymal cells, are the main contributors to neuropathic pain following spinal cord injury (SCI). Selective elimination of resident astrocytes in the lumbar enlargement of mice with SCI resulted in significant pain reduction. The pain relief observed after astrocyte elimination is linked to the activation of the type I interferon (IFN) signaling pathway in microglia, suggesting a potential therapeutic target for neuropathic pain after SCI.

Practical Implications

Therapeutic Target Identification

Type I IFNs signals may represent a novel therapeutic target for the treatment of neuropathic pain following SCI.

Astrocyte Specific Targeting

Targeting resident astrocytes specifically can reduce neuropathic pain.

Microglia Involvement

Microglia activation and the type I IFN pathway are crucial in mediating pain relief after astrocyte elimination, offering insights into potential therapeutic mechanisms.

Study Limitations

  • 1
    Astrocyte elimination is difficult to achieve in clinical practice.
  • 2
    Observed effects may be a side effect of the elimination of astrocytes.
  • 3
    Experiments did not identify whether diphtheria toxin-­induced cell apoptosis leads to the activation of the type I IFNs signaling pathway

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury